Inflammatory Cytokines and TME Modulators

"Inflammatory cytokines and TME modulators" is a collective term for various soluble proteins released by tumor cells, immune cells, stromal cells, and other components of the tumor microenvironment. These factors, including interleukins (ILs), tumor necrosis factor (TNF), transforming growth factor beta (TGF-β), interferons (IFNs), chemokines, and others, orchestrate a complex interplay of pro- and anti-inflammatory signals that regulate immune cell behavior, angiogenesis, tumor cell proliferation, differentiation, invasion, and metastasis. Depending on context, inflammatory cytokines may promote tumor immune evasion, support metastasis by remodeling the extracellular matrix and angiogenesis, or, alternatively, stimulate anti-tumor immunity. Because of their pleiotropic and context-dependent roles in cancer and other pathologies, "inflammatory cytokines and TME modulators" is not a specific therapeutic target but rather encompasses multiple interrelated pathways and is best described as a target class[1][2][3][4][5]. This entry is therefore not a canonical molecular target in the sense required for structured pharmacological databases; instead, it refers to a group or network of related, well-defined targets.

Other names

Inflammatory cytokinesTumor microenvironment modulatorsTME cytokinesPro-inflammatory cytokines

Neutralization of specific cytokines (blocking function or signaling) Inhibition of cytokine receptor signaling Immune activation or suppression within the TME Modulation of immune cell recruitment and function